Correlation Between Karyopharm Therapeutics and Alpha Tau

Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Alpha Tau at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Alpha Tau into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Karyopharm Therapeutics and Alpha Tau Medical, you can compare the effects of market volatilities on Karyopharm Therapeutics and Alpha Tau and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Alpha Tau. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Alpha Tau.

Diversification Opportunities for Karyopharm Therapeutics and Alpha Tau

-0.63

Correlation Coefficient

Karyopharm Therapeutics  Alpha Tau

Excellent diversification

The 3 months correlation between Karyopharm and Alpha is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Alpha Tau Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Tau Medical and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Alpha Tau. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Tau Medical has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Alpha Tau go up and down completely randomly.

Pair Corralation between Karyopharm Therapeutics and Alpha Tau

Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Alpha Tau. In addition to that, Karyopharm Therapeutics is 1.44 times more volatile than Alpha Tau Medical. It trades about -0.03 of its total potential returns per unit of risk. Alpha Tau Medical is currently generating about 0.01 per unit of volatility. If you would invest  339.00  in Alpha Tau Medical on September 26, 2024 and sell it today you would lose (30.00) from holding Alpha Tau Medical or give up 8.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Karyopharm Therapeutics  vs.  Alpha Tau Medical

Karyopharm Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Karyopharm Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Alpha Tau Medical

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Alpha Tau unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Karyopharm Therapeutics and Alpha Tau

The main advantage of trading using opposite Karyopharm Therapeutics and Alpha Tau positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Alpha Tau can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Tau will offset losses from the drop in Alpha Tau's long position.

The idea behind Karyopharm Therapeutics and Alpha Tau Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.